share_log

Beyond The Numbers: 25 Analysts Discuss Eli Lilly Stock

Beyond The Numbers: 25 Analysts Discuss Eli Lilly Stock

数字之外:25位分析师讨论了礼来股票
Benzinga ·  08/12 08:00
Analysts' ratings for Eli Lilly (NYSE:LLY) over the last quarter vary from bullish to bearish, as provided by 25 analysts.
最近25位分析师对Eli Lilly(纽交所:LLY)的评级从看好到看淡各不相同。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他们最近评级的精简视图,显示了过去30天的不同情绪,并将其与前几个月进行比较。
Analysts have recently evaluated Eli Lilly and provided 12-month price targets. The average target is $955.64, accompanied by a high estimate of $1125.00 and a low estimate of $884.00. This current average reflects an increase of 5.3% from the previous average price target of $907.56.
分析师最近对Eli Lilly进行了评估,并提供了12个月的股价目标。 平均目标价格为$ 955.64,高估为$ 1125.00,低估为$ 884.00。 当前的平均目标价格较上一个平均价格目标$ 907.56上涨了5.3%。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析师评级:详细剖析
The standing of Eli Lilly among financial experts...
通过对分析师行动...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发